Skip to main navigation
Skip to search
Skip to main content
Ciência-UCP | Universidade Católica Portuguesa Home
Help & FAQ
English
Português
Home
Units
Projects
Profiles
Research output
Activities
Prizes
Student theses
Press/Media
Datasets
Equipment
Impacts
Search by expertise, name or affiliation
De-escalation of therapy in inflammatory bowel disease
Catarina Frias Gomes
, Jean Frédéric Colombel
*
,
Joana Torres
*
Corresponding author for this work
Research output
:
Contribution to journal
›
Review article
›
peer-review
11
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'De-escalation of therapy in inflammatory bowel disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Inflammatory Bowel Disease
100%
Immunomodulating Agent
100%
Biological Product
50%
Combination Therapy
50%
Drug Dose Reduction
50%
Health Care Cost
50%
Therapeutic Management
50%
Therapeutic Drug Monitoring
50%
Drug Withdrawal
50%
Side Effect
50%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammatory Bowel Disease
100%
Immunomodulating Agent
100%
Biological Product
50%
Combination Therapy
50%
Therapeutic Drug Monitoring
50%
Side Effect
50%